$1.37 Billion is the total value of Bronte Capital Management Pty Ltd.'s 27 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 0.0% . Bronte Capital Management Pty Ltd. is a registered-investment adviser.
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | Sell | SPDR S&P 500 ETF TRcall | $182,640,000 | -18.7% | 42,400 | -18.9% | 13.36% | -16.6% |
| IWO | Sell | ISHARES TRcall | $135,844,000 | -16.1% | 462,700 | -10.9% | 9.94% | -13.9% |
| BRKB | Sell | BERKSHIRE HATHAWAY INC DELcl b new | $113,695,000 | -3.5% | 416,558 | -1.8% | 8.32% | -1.0% |
| BNTX | Sell | BIONTECH SE-ADRsponsored ads | $1,855,000 | -24.4% | 6,795 | -38.0% | 0.14% | -22.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BERKSHIRE HATHAWAY INC DEL | 20 | Q3 2023 | 22.6% |
| ALPHABET INC-CL A | 20 | Q3 2023 | 14.4% |
| HERBALIFE NUTRITION LTD | 20 | Q3 2023 | 22.0% |
| INTERACTIVE BROKERS GROUP | 20 | Q3 2023 | 12.4% |
| ALPHABET INC-CL C | 20 | Q3 2023 | 5.7% |
| VISA INC-CLASS A SHARES | 19 | Q2 2023 | 16.6% |
| CORTEVA NC | 17 | Q3 2023 | 6.2% |
| GRAHAM HOLDINGS CO-CLASS B | 13 | Q3 2023 | 2.1% |
| REGENERON PHARMACEUTICALS | 12 | Q3 2023 | 13.0% |
| STATE STREET CORP | 12 | Q2 2023 | 3.0% |
View Bronte Capital Management Pty Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| SCHEDULE 13G | 2024-02-13 |
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-03 |
| 13F-HR/A | 2022-08-08 |
| 13F-HR | 2022-08-08 |
| 13F-HR | 2022-05-13 |
View Bronte Capital Management Pty Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.